Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders

Keyphrases

• Brain-derived Neurotrophic Factor 16%
• Connective Tissue Growth Factor 16%
• Crohn's Disease 16%
• Cyclooxygenase-2 16%
• Fibrosis 16%
• Fibrostenotic 16%
• Functional Bowel Disorders 16%
• Functional Disorders 16%
• Gastrointestinal Diseases 100%
• Gastrointestinal Tract 16%
• Gene Expression 16%
• Gene Transcription 16%
• Growth Factors 33%
• Gut Smooth muscle 16%
• Hollow Organs 16%
• Inflammation 16%
• Inflammatory Bowel Disease 16%
• Inflammatory Disorders 16%
• Inflammatory Mediators 16%
• Inflammatory Molecules 16%
• Inflammatory Process 16%
• Mechanical Stress 100%
• Motility Disorders 33%
• Nerve Growth Factor 16%
• Osteopontin 16%
• Pain Mediators 50%
• Pro-fibrotic Factors 33%
• Pro-growth 33%
• Pro-inflammatory Molecules 16%
• Profibrotic 16%
• Putative Drug Targets 16%
• Smooth muscle Cells 16%
• Stress-induced 16%
• Stress-induced Expression 16%
• Therapeutic Intervention 100%
• Transcription Process 100%
• Visceral Hypersensitivity 33%

Medicine and Dentistry

• Brain Derived Neurotrophic Factor 25%
• Connective Tissue Growth Factor 25%
• Crohn's Disease 25%
• Cyclooxygenase 2 25%
• Disease 25%
• Enteropathy 25%
• Fibrosis 25%
• Functional Disorder 25%
• Gastrointestinal Disease 100%
• Gastrointestinal Tract 25%
• Gene Expression 25%
• Genetic Transcription 25%
• Growth Factor 50%
• Gut 75%
• Hypersensitivity 50%
• Inflammatory Disorder 25%
• Inflammatory Mediator 25%
• Mediator 100%
• Nerve Growth Factor 25%
• Osteopontin 25%
• Serositis 25%
• Smooth Muscle Cell 25%
• Upregulation 25%